fda drug shortage list semaglutide status january 2025 Declares of Novo Nordisk's Wegovy, Ozempic Over Ozempic® GLP for Weight Loss

GLP-1 receptor agonists like semaglutide (Ozempic), liraglutide (Victoza), and tirzepatide (Mounjaro) help by increasing insulin secretion in response to meals, thereby lowering blood sugar levels

Some small trials have explored low-dose naltrexone (LDN) alongside semaglutide or other GLP-1 medications, with preliminary findings suggesting additive weight loss benefits in select populations

Maintaining this distinction is essential to avoid repeating the conceptual errors that have driven a century of failed attempts to develop classical oral delivery

All work under the medical direction of Patricia Arledge, MD, our plastic surgeon Medical Director

For the non-randomized/observational studies, the methodological quality was assessed using Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I)